Spontaneous intracerebral hemorrhage (ICH) is a common and often fatal stroke subtype. If the patient survives the ictus, the resulting hematoma within the brain parenchyma triggers a series of events leading to secondary insults and severe neurological deficits. After an ICH, lysis of erythrocytes in the hematoma and the mass itself result in brain swelling, neuronal death and neurological deficits. The hematoma can be removed by surgery or naturally by microglia/ macrophages. Our previous studies demonstrated that surgical clot removal with tissue plasminogen activator (tPA) reduces acute perihematomal edema in pigs. Recent studies found that enhancing microglia/ macrophage-mediated hematoma clearance reduces ICH-induced brain edema and improves functional outcome. CD47, also called integrin-associated protein, is expressed on erythrocytes and other cells regulating target cell phagocytosis. The role of CD47 in ICH has not been well studied. In preliminary studies, we found: 1) CD47 is expressed in rodent and pig erythrocytes; 2) erythrophagocytosis occurs in the perihematomal area and in the clot in both mouse and pig ICH models; 3) hematoma clearance is faster when the ICH is formed using CD47 knockout blood in mice; 4) the injection of CD47 knockout blood causes less brain swelling and neurological deficits than wild-type blood; and 5) co-injection of clodronate liposomes depletes M2 microglia/macrophages and causes more brain swelling and less hematoma clearance. These results suggest that CD47 inhibition is a target for reducing ICH-induced brain injury. Recently, there has been considerable interest in the cancer field in targeting CD47 with blocking antibodies to enhance phagocytosis and that approach is currently in clinical trial. In this application, we propose to test the following specific aims: 1) To examine whether CD47 levels in the hematoma are associated with infiltration of macrophages/microglia into the clot and clot clearance; 2) To examine whether modifying erythrocyte CD47 levels in the clot or blocking CD47 will affect hematoma clearance and ICH-induced brain injury in aged mice and in pigs; and 3) To determine whether blocking CD47 plus surgical clot removal with tPA will significantly reduce ICH-induced white matter injury. The long-term goal of our studies is to limit brain damage following ICH.

Public Health Relevance

After a cerebral hemorrhage, lysis of red blood cells causes a build up of iron in the brain and brain iron accumulation can cause brain cell death and neurological deficits. Recent studies suggest that hematoma clearance is a therapeutic target of brain hemorrhage and enhancing clot clearance reduces hemorrhage- induced neurological deficits. The purpose of this project is to investigate the role of CD47 in clot clearance and cerebral hemorrhage-induced brain injury without and with surgical removal. The long-term goal of our studies is to limit brain damage following cerebral hemorrhage.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Koenig, James I
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Schools of Medicine
Ann Arbor
United States
Zip Code
Cao, Shenglong; Hua, Ya; Keep, Richard F et al. (2018) Minocycline Effects on Intracerebral Hemorrhage-Induced Iron Overload in Aged Rats: Brain Iron Quantification With Magnetic Resonance Imaging. Stroke 49:995-1002
Bao, Xuhui; Hua, Ya; Keep, Richard F et al. (2018) Thrombin-induced tolerance against oxygen-glucose deprivation in astrocytes: role of protease-activated receptor-1. Cond Med 1:57-63
Keep, Richard F; Andjelkovic, Anuska V; Xiang, Jianming et al. (2018) Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets. J Cereb Blood Flow Metab 38:1255-1275
Wilkinson, D Andrew; Pandey, Aditya S; Thompson, B Gregory et al. (2018) Injury mechanisms in acute intracerebral hemorrhage. Neuropharmacology 134:240-248
Liu, Ran; Cao, Shenglong; Hua, Ya et al. (2017) CD163 Expression in Neurons After Experimental Intracerebral Hemorrhage. Stroke 48:1369-1375
Xiang, Jianming; Routhe, Lisa J; Wilkinson, D Andrew et al. (2017) The choroid plexus as a site of damage in hemorrhagic and ischemic stroke and its role in responding to injury. Fluids Barriers CNS 14:8
Garton, Thomas; Hua, Ya; Xiang, Jianming et al. (2017) Challenges for intraventricular hemorrhage research and emerging therapeutic targets. Expert Opin Ther Targets 21:1111-1122
Dang, Ge; Yang, Yuefan; Wu, Gang et al. (2017) Early Erythrolysis in the Hematoma After Experimental Intracerebral Hemorrhage. Transl Stroke Res 8:174-182
Guo, Dewei; Wilkinson, D Andrew; Thompson, B Gregory et al. (2017) MRI Characterization in the Acute Phase of Experimental Subarachnoid Hemorrhage. Transl Stroke Res 8:234-243
Ni, Wei; Mao, Shanshan; Xi, Guohua et al. (2016) Role of Erythrocyte CD47 in Intracerebral Hematoma Clearance. Stroke 47:505-11

Showing the most recent 10 out of 15 publications